For the quarter ended August 2026, Neogen (NEOG Quick QuoteNEOG - Free Report) reported revenue of $222.8 million, up 6.5% over the same period last year. EPS came in at $0.08, compared to $0.04 in the year-ago quarter.

The reported revenue represents a surprise of +7.07% over the Zacks Consensus Estimate of $208.09 million. With the consensus EPS estimate being $0.05, the EPS surprise was +60%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Neogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Food Safety: $163.2 million versus the two-analyst average estimate of $152.85 million. The reported number represents a year-over-year change of +7.3%.
• Revenues- Animal Safety: $59.6 million versus the two-analyst average estimate of $55.08 million. The reported number represents a year-over-year change of +4.3%.
• Revenues- Food Safety- Natural Toxins & Allergens: $19.3 million compared to the $20.15 million average estimate based on two analysts. The reported number represents a change of -3.3% year over year.
• Revenues- Food Safety- Bacterial & General Sanitation: $44.6 million versus $42.44 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.1% change.
• Revenues- Animal Safety- Genomics Services: $17.3 million compared to the $17.43 million average estimate based on two analysts. The reported number represents a change of +211.4% year over year.
• Revenues- Food Safety- Genomics Services: $6.7 million versus the two-analyst average estimate of $5.11 million. The reported number represents a year-over-year change of -59.6%.
• Revenues- Animal Safety- Life Sciences: $1.6 million versus the two-analyst average estimate of $1.92 million. The reported number represents a year-over-year change of -13.9%.
• Revenues- Animal Safety- Veterinary Instruments & Disposables: $14.1 million compared to the $11.55 million average estimate based on two analysts. The reported number represents a change of +18.4% year over year.
• Revenues- Animal Safety- Animal Care & Other: $7.7 million versus the two-analyst average estimate of $6.89 million. The reported number represents a year-over-year change of +1.6%.
• Revenues- Food Safety- Indicator Testing, Culture Media: $85.6 million versus the two-analyst average estimate of $80.8 million. The reported number represents a year-over-year change of +8.2%.

View all Key Company Metrics for Neogen here>>>

Shares of Neogen have returned +10% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.